Top Markets
Coin of the day
Evaxion Biotech A/S Evaxion Biotech A/S

Evaxion Biotech A/S

EVAX
Rang in Aktien #29740
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to... Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.
Aktienkurs
$3.14
Zuletzt synchronisiert: 2026-08-18
Marktkapitalisierung
$19.83M
Veränderung (1 Tag)
0.32%
Veränderung (1 Jahr)
3.29%
Land
DK
Handel Evaxion Biotech A/S (EVAX)

Kategorie

Kursverlauf für Evaxion Biotech A/S (EVAX)
Höchster Schlusskurs: $3.12 am 2026-08-01

Niedrigster Schlusskurs: $427.70 am 2021-02-01
Kursverlauf der Aktie von Evaxion Biotech A/S von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -23.56%
2025 -2.32%
2024 -83.73%
2023 -64.17%
2022 -54.86%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$743.14 7.12%
CH
$1.07K -5.58%
KR